Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP238704.RADvcU96f0sEoU-e-U2J2sMVExY6xhvVj5u1hg48U_PV4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP238704.RADvcU96f0sEoU-e-U2J2sMVExY6xhvVj5u1hg48U_PV4130_assertion type Assertion NP238704.RADvcU96f0sEoU-e-U2J2sMVExY6xhvVj5u1hg48U_PV4130_head.
- NP238704.RADvcU96f0sEoU-e-U2J2sMVExY6xhvVj5u1hg48U_PV4130_assertion wasGeneratedBy ECO_0000203 NP238704.RADvcU96f0sEoU-e-U2J2sMVExY6xhvVj5u1hg48U_PV4130_provenance.
- NP238704.RADvcU96f0sEoU-e-U2J2sMVExY6xhvVj5u1hg48U_PV4130_assertion wasDerivedFrom befree-20140225 NP238704.RADvcU96f0sEoU-e-U2J2sMVExY6xhvVj5u1hg48U_PV4130_provenance.
- NP238704.RADvcU96f0sEoU-e-U2J2sMVExY6xhvVj5u1hg48U_PV4130_assertion SIO_000772 18092840 NP238704.RADvcU96f0sEoU-e-U2J2sMVExY6xhvVj5u1hg48U_PV4130_provenance.
- NP238704.RADvcU96f0sEoU-e-U2J2sMVExY6xhvVj5u1hg48U_PV4130_assertion evidence source_evidence_literature NP238704.RADvcU96f0sEoU-e-U2J2sMVExY6xhvVj5u1hg48U_PV4130_provenance.
- NP238704.RADvcU96f0sEoU-e-U2J2sMVExY6xhvVj5u1hg48U_PV4130_assertion description "[This observation suggests the possibility that PPARalpha and PPARgamma activators, or compounds that positively regulate PPAR gene expression, may represent novel NSAIDs for the topical or systemic treatment of common inflammatory skin diseases such as atopic dermatitis, psoriasis, and allergic contact dermatitis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP238704.RADvcU96f0sEoU-e-U2J2sMVExY6xhvVj5u1hg48U_PV4130_provenance.